CBR4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.038000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.913200E-01
Normal-vs-Stage2
2.560800E-03
Normal-vs-Stage3
2.814900E-04
Normal-vs-Stage4
1.662220E-02
Stage1-vs-Stage2
1.423760E-03
Stage1-vs-Stage3
2.607500E-02
Stage1-vs-Stage4
1.349850E-01
Stage2-vs-Stage3
1.543180E-01
Stage2-vs-Stage4
9.055600E-01
Stage3-vs-Stage4
2.090200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.252000E-02
Normal-vs-AfricanAmerican
1.240000E-01
Normal-vs-Asian
3.381800E-02
Caucasian-vs-AfricanAmerican
3.994800E-01
Caucasian-vs-Asian
5.394000E-01
AfricanAmerican-vs-Asian
2.824800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.896000E-02
Normal-vs-Female
3.830300E-02
Male-vs-Female
3.503600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.937600E-01
Normal-vs-Age(41-60Yrs)
4.711600E-02
Normal-vs-Age(61-80Yrs)
2.625700E-02
Normal-vs-Age(81-100Yrs)
3.819500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.930400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.795200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.955600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.965900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.410800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.014000E-04
Normal-vs-Daily Drinker
1.535550E-02
Normal-vs-Weekly Drinker
8.20679999999907E-05
Normal-vs-Occasional Drinker
3.969600E-02
Normal-vs-Social Drinker
2.265200E-01
Non Drinker-vs-Daily Drinker
7.697600E-01
Non Drinker-vs-Weekly Drinker
1.095040E-01
Non Drinker-vs-Occasional Drinker
2.728200E-01
Non Drinker-vs-Social Drinker
9.707800E-02
Daily Drinker-vs-Weekly Drinker
1.583160E-01
Daily Drinker-vs-Occasional Drinker
5.188000E-01
Daily Drinker-vs-Social Drinker
1.458190E-01
Weekly Drinker-vs-Occasional Drinker
4.775500E-02
Weekly Drinker-vs-Social Drinker
1.559590E-02
Occasional Drinker-vs-Social Drinker
3.869000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.070390E-01
Normal-vs-Grade 2
9.316500E-03
Normal-vs-Grade 3
5.179700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.886200E-02
Grade 1-vs-Grade 3
6.441600E-02
Grade 1-vs-Grade 4
1.070390E-01
Grade 2-vs-Grade 3
7.612000E-01
Grade 2-vs-Grade 4
9.316500E-03
Grade 3-vs-Grade 4
5.179700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.029800E-04
Normal-vs-NonDiabetic
4.555900E-02
Diabetic-vs-NonDiabetic
1.030630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.869500E-02
Normal-vs-NoPancreatitis
2.305900E-02
Pancreatitis-vs-NoPancreatitis
7.588800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.183700E-04
Normal-vs-N1
2.060000E-03
N0-vs-N1
1.079000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.698350E-02
Normal-vs-TP53-NonMutant
3.604400E-01
TP53-Mutant-vs-TP53-NonMutant
1.741920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
